• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤浸润淋巴细胞计数高与晚期卵巢癌独特的基因表达谱及患者较长生存期相关。

High Tumor-Infiltrating Lymphocyte Count Is Associated with Distinct Gene Expression Profile and Longer Patient Survival in Advanced Ovarian Cancer.

作者信息

Barna Andras Jozsef, Herold Zoltan, Acs Miklos, Bazsa Sandor, Gajdacsi Jozsef, Garay Tamas Marton, Herold Magdolna, Madaras Lilla, Muhl Dorottya, Nagy Akos, Szasz Attila Marcell, Dank Magdolna

机构信息

Department of Obstetrics and Gynecology, Saint Pantaleon Hospital, H-2400 Dunaujvaros, Hungary.

Division of Oncology, Department of Internal Medicine and Oncology, Semmelweis University, H-1083 Budapest, Hungary.

出版信息

Int J Mol Sci. 2023 Sep 5;24(18):13684. doi: 10.3390/ijms241813684.

DOI:10.3390/ijms241813684
PMID:37761986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10530512/
Abstract

Cancer-related immunity plays a significant role in the outcome of ovarian cancer, but the exact mechanisms are not fully explored. A retrospective, real-life observational study was conducted including 57 advanced ovarian cancer patients. Immunohistochemistry for CD4, CD8, and CD45 was used for assessing tumor-infiltrating immune cells. Furthermore, an immune-related gene expression assay was performed on 12-10 samples from patients with less than and more than 1-year overall survival (OS), respectively. A higher number of CD4 ( = 0.0028) and CD45 ( = 0.0221) immune cells within the tumor microenvironment were associated with longer OS of patients. In a multivariate setting, higher CD4 T cell infiltration predicted longer OS ( = 0.0392). Twenty-three differentially expressed genes-involved in antigen presentation, costimulatory signaling, matrix remodeling, metastasis formation, and myeloid cell activity-were found when comparing the prognostic groups. It was found that tumor-infiltrating immune cell counts are associated with peculiar gene expression patterns and bear prognostic information in ovarian cancer. expression emerged and was validated as a predictive marker for OS.

摘要

癌症相关免疫在卵巢癌的预后中起着重要作用,但确切机制尚未完全阐明。我们开展了一项回顾性、基于真实生活的观察性研究,纳入了57例晚期卵巢癌患者。采用CD4、CD8和CD45免疫组织化学方法评估肿瘤浸润免疫细胞。此外,分别对总生存期(OS)小于1年和大于1年的患者各12 - 10份样本进行了免疫相关基因表达检测。肿瘤微环境中CD4(P = 0.0028)和CD45(P = 0.0221)免疫细胞数量较多与患者较长的OS相关。在多变量分析中,较高的CD4 T细胞浸润预示着较长的OS(P = 0.0392)。在比较预后组时,发现了23个差异表达基因,这些基因涉及抗原呈递、共刺激信号传导、基质重塑、转移形成和髓样细胞活性。研究发现,肿瘤浸润免疫细胞计数与特定的基因表达模式相关,并在卵巢癌中具有预后信息。发现……表达出现并被验证为OS的预测标志物。 (注:原文中“expression emerged and was validated as a predictive marker for OS.”前似乎缺少关键信息)

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f08/10530512/c1b296846cce/ijms-24-13684-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f08/10530512/48574ad517d3/ijms-24-13684-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f08/10530512/ada0002fb1db/ijms-24-13684-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f08/10530512/bdf11b8556bd/ijms-24-13684-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f08/10530512/09e1063bb232/ijms-24-13684-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f08/10530512/80f91d0e72ba/ijms-24-13684-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f08/10530512/c1b296846cce/ijms-24-13684-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f08/10530512/48574ad517d3/ijms-24-13684-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f08/10530512/ada0002fb1db/ijms-24-13684-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f08/10530512/bdf11b8556bd/ijms-24-13684-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f08/10530512/09e1063bb232/ijms-24-13684-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f08/10530512/80f91d0e72ba/ijms-24-13684-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3f08/10530512/c1b296846cce/ijms-24-13684-g006.jpg

相似文献

1
High Tumor-Infiltrating Lymphocyte Count Is Associated with Distinct Gene Expression Profile and Longer Patient Survival in Advanced Ovarian Cancer.肿瘤浸润淋巴细胞计数高与晚期卵巢癌独特的基因表达谱及患者较长生存期相关。
Int J Mol Sci. 2023 Sep 5;24(18):13684. doi: 10.3390/ijms241813684.
2
Predictors of Response to Autologous Dendritic Cell Therapy in Glioblastoma Multiforme.预测胶质母细胞瘤患者对自体树突状细胞瘤治疗的反应。
Front Immunol. 2018 May 29;9:727. doi: 10.3389/fimmu.2018.00727. eCollection 2018.
3
Prognostic value of tumor PD-L1 expression combined with CD8 tumor infiltrating lymphocytes in high grade serous ovarian cancer.肿瘤 PD-L1 表达联合 CD8 肿瘤浸润淋巴细胞对高级别浆液性卵巢癌的预后价值。
Int Immunopharmacol. 2017 Nov;52:7-14. doi: 10.1016/j.intimp.2017.08.017. Epub 2017 Aug 31.
4
Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer.肿瘤上皮中HLA - DMB表达增加与晚期浆液性卵巢癌中CTL浸润增加及预后改善相关。
Clin Cancer Res. 2008 Dec 1;14(23):7667-73. doi: 10.1158/1078-0432.CCR-08-0479.
5
Higher Numbers of T-Bet+ Tumor-Infiltrating Lymphocytes Associate with Better Survival in Human Epithelial Ovarian Cancer.较高数量的T-bet+肿瘤浸润淋巴细胞与人类上皮性卵巢癌更好的生存率相关。
Cell Physiol Biochem. 2017;41(2):475-483. doi: 10.1159/000456600. Epub 2017 Jan 30.
6
Characterization of immunoreactivity with whole-slide imaging and digital analysis in high-grade serous ovarian cancer.高级别浆液性卵巢癌中全切片成像和数字分析的免疫反应性特征
Tumour Biol. 2020 Nov;42(11):1010428320971404. doi: 10.1177/1010428320971404.
7
Patient inflammatory status and CD4+/CD8+ intraepithelial tumor lymphocyte infiltration are predictors of outcomes in high-grade serous ovarian cancer.患者炎症状态和 CD4+/CD8+上皮内肿瘤淋巴细胞浸润是高级别浆液性卵巢癌结局的预测因素。
Gynecol Oncol. 2018 Oct;151(1):10-17. doi: 10.1016/j.ygyno.2018.07.025. Epub 2018 Aug 2.
8
Prognostic markers of inflammation in endometrioid and clear cell ovarian cancer.子宫内膜样和透明细胞卵巢癌中炎症的预后标志物。
Int J Gynecol Cancer. 2022 Aug 1;32(8):1009-1016. doi: 10.1136/ijgc-2022-003353.
9
Prognostic and clinicopathological significance of PD-L1 and tumor infiltrating lymphocytes in hypopharyngeal squamous cell carcinoma.PD-L1 和肿瘤浸润淋巴细胞在下咽鳞状细胞癌中的预后及临床病理意义。
Oral Oncol. 2020 Mar;102:104560. doi: 10.1016/j.oraloncology.2019.104560. Epub 2020 Jan 7.
10
VISTA+/CD8+ status correlates with favorable prognosis in Epithelial ovarian cancer.VISTA+/CD8+ 状态与上皮性卵巢癌的良好预后相关。
PLoS One. 2023 Mar 23;18(3):e0278849. doi: 10.1371/journal.pone.0278849. eCollection 2023.

引用本文的文献

1
Association of Tumor-Infiltrating Lymphocytes and Inflammation Status with Survival Outcome in Patients with High-Grade Serous Ovarian Carcinoma.高级别浆液性卵巢癌患者肿瘤浸润淋巴细胞及炎症状态与生存结局的相关性
Cancers (Basel). 2025 Jul 8;17(14):2269. doi: 10.3390/cancers17142269.
2
The causal effects of genetically determined immune cells on gynecologic malignancies: a Mendelian randomization study.基因决定的免疫细胞对妇科恶性肿瘤的因果效应:一项孟德尔随机化研究。
Front Oncol. 2024 Apr 30;14:1371309. doi: 10.3389/fonc.2024.1371309. eCollection 2024.
3
Impact of preoperative white blood cell count on outcomes in different stage colorectal cancer patients undergoing surgical resection: a single-institution retrospective cohort study.

本文引用的文献

1
Differential molecular pathway expression according to chemotherapeutic response in ovarian clear cell carcinoma.根据卵巢透明细胞癌的化疗反应差异分子途径表达。
BMC Womens Health. 2023 Jun 3;23(1):298. doi: 10.1186/s12905-023-02420-1.
2
Tumor immune microenvironment changes are associated with response to neoadjuvant chemotherapy and long-term survival benefits in advanced epithelial ovarian cancer: A pilot study.肿瘤免疫微环境变化与晚期上皮性卵巢癌新辅助化疗反应和长期生存获益相关:一项初步研究。
Front Immunol. 2023 Mar 13;14:1022942. doi: 10.3389/fimmu.2023.1022942. eCollection 2023.
3
Discovery and ranking of the most robust prognostic biomarkers in serous ovarian cancer.
术前白细胞计数对不同分期结直肠癌患者手术切除后结局的影响:单中心回顾性队列研究。
BMC Cancer. 2024 Feb 21;24(1):242. doi: 10.1186/s12885-024-11983-7.
发现和评估浆液性卵巢癌中最稳健的预后生物标志物。
Geroscience. 2023 Jun;45(3):1889-1898. doi: 10.1007/s11357-023-00742-4. Epub 2023 Mar 1.
4
Spatial heterogeneity of infiltrating T cells in high-grade serous ovarian cancer revealed by multi-omics analysis.多组学分析揭示高级别浆液性卵巢癌浸润 T 细胞的空间异质性。
Cell Rep Med. 2022 Dec 20;3(12):100856. doi: 10.1016/j.xcrm.2022.100856.
5
Tumor-infiltrating lymphocytes for treatment of solid tumors: It takes two to tango?浸润肿瘤的淋巴细胞治疗实体瘤:需要双人探戈?
Front Immunol. 2022 Oct 28;13:1018962. doi: 10.3389/fimmu.2022.1018962. eCollection 2022.
6
Profiling the immune landscape in mucinous ovarian carcinoma.分析黏液性卵巢癌的免疫图谱。
Gynecol Oncol. 2023 Jan;168:23-31. doi: 10.1016/j.ygyno.2022.10.022. Epub 2022 Nov 8.
7
Improving PARP inhibitor efficacy in high-grade serous ovarian carcinoma: A focus on the immune system.提高PARP抑制剂在高级别浆液性卵巢癌中的疗效:聚焦免疫系统。
Front Genet. 2022 Sep 9;13:886170. doi: 10.3389/fgene.2022.886170. eCollection 2022.
8
Adaptive transcriptomic and immune infiltrate responses in the tumor immune microenvironment following neoadjuvant chemotherapy in high grade serous ovarian cancer reveal novel prognostic associations and activation of pro-tumorigenic pathways.新辅助化疗后高级别浆液性卵巢癌肿瘤免疫微环境中的适应性转录组和免疫浸润反应揭示了新的预后相关性和促肿瘤发生途径的激活。
Front Immunol. 2022 Sep 5;13:965331. doi: 10.3389/fimmu.2022.965331. eCollection 2022.
9
The Tumor Microenvironment of Clear-Cell Ovarian Cancer.《透明细胞卵巢癌的肿瘤微环境》。
Cancer Immunol Res. 2022 Nov 2;10(11):1326-1339. doi: 10.1158/2326-6066.CIR-22-0407.
10
Pan-cancer analyses and molecular subtypes based on the cancer-associated fibroblast landscape and tumor microenvironment infiltration characterization reveal clinical outcome and immunotherapy response in epithelial ovarian cancer.基于癌症相关成纤维细胞景观和肿瘤微环境浸润特征的泛癌分析和分子亚型揭示了上皮性卵巢癌的临床结局和免疫治疗反应。
Front Immunol. 2022 Aug 10;13:956224. doi: 10.3389/fimmu.2022.956224. eCollection 2022.